Global ETD Search
Search theses and dissertations gathered from participating repositories worldwide. Every result links back to the library that holds it. No account is needed.
Results
Showing 1 to 20 of 66 for “"Melphalan"”.
-
Understanding the inter-individual intrinsic factors that may influence response to melphalan
Myeloablative therapy with melphalan prior to autologous stem cell transplantation remains the standard treatment for newly diagnosed multiple myeloma patients. Despite being effective for disease remission, ~15% have little or no response. Covariates that result in sub-therapeutic plasma …
-
Identifying responders to melphalan and dexamethasone for newly diagnosed multiple myeloma patients
… MY7 clinical trial compared dexamethasone plus melphalan (MD) vs. prednisone plus melphalan (MP) in multiple myeloma treatment and found no statistically significant difference in overall survival (OS) between the two groups. But, patients reacted to treatment differently. We aimed to identify …
-
Genotoxic effects in cancer patients after treatment with single drug etoposide or melphalan chemotherapy
… genotoxic effects of two agents, etoposide and melphalan, in cancer patients receiving single drug chemotherapy. Both drugs are potent mutagens; and have been implicated as causative agents of secondary acute myeloid leukemia (sAML). Two groups of patients were studied: small cell lung cancer …
-
The Role of Small Peptides in Cancer Physiology and Chemotherapy
… to permeant metabolites, in targeting the drug melphalan to mouse Ehrlich ascites tumor cells. The dipeptide beta-alanyl-melphalan was synthesized and tested in vitro for toxicity towards mouse Ehrlich ascites tumor cells, mouse liver cells, and mouse 3T3 embryonic cells. The parent compound, …
-
Investigation of multidrug resistance and invasion in human cancer cell lines
Through exposure to melphalan or taxol, four novel multidrug resistant variants of the human nasal carcinoma cell line, RPMI-2650 and human lung carcinoma cell line, DLKP, were established In vitro toxicity tests revealed that the RPMI-2650 taxol-resistant variant exhibited significant resistance …
-
The Fanconi Anemia (FA)/BRCA DNA Damage Repair Pathway is Regulated by NF-κB and Mediates Drug Resistance in Multiple Myeloma
… (MM) cell lines selected for resistance to melphalan. We hypothesized that the FA/BRCA DNA damage repair pathway mediates response and resistance to chemotherapeutic agents used to treat multiple myeloma and other cancers, and targeting this pathway is vital to overcoming drug resistance. In …
-
Συμβολή στη μελέτη των ιστοπαθολογικών αλλοιώσεων του γεννητικού συστήματος του άρρενος και των μεταβολών των χαρακτηριστικών του σπέρματος στους επίμυες μετά από χορήγηση του αντινεοπλασματικού φαρμάκου Melphalan
Melphalan is an alkylating chemotherapeutic agent currently used alone or in combination with other antiproliferative agents in the treatment of various neoplasms, such as multiple myeloma, leukaemia, lymphoma and neuroblastoma. Several lines of evidence suggest that chemotherapeutic regimens that …
-
Assessment of Delivery of Therapeutic Agents in Isolated Limb Perfusion for Malignant Melanoma
… have been quantified in a comparative study of melphalan pharmacokinetics, the "quality" of perfusion, uptake of melphalan by the skin, and leakage of melphalan to the systemic circulation in 38 ILPs. This reveals no direct correlation between the quality of perfusion and the concentration of …
-
Synthese und Testung neuer Dendrimer-Zytostatika-Konjugate
Bendamustin und Melphalan sind Stickstoff-Lost-Derivate aus der Gruppe der Alkylanzien und werden für die Behandlung von verschiedenen Tumorerkrankungen z.B. chronischer lymphatischer Leukämie (CLL) oder Brustkrebs eingesetzt. Ihre Anwendung wird jedoch durch zahlreiche Nebenwirkungen begrenzt. …
-
Chemotherapy-Induced Damage of the Bone Marrow Microenvironment
… the first study, we investigated the effects of melphalan and Etoposide (VP-16) treatment on osteoblasts. Previous studies from our lab had shown that chemotherapy treatment increased the amount of active TGF-beta secreted from BMSC, leading to decreases in the ability to support pro-B cells. …
-
The biology and chemosensitivity of ovarian cancer in vivo and in vitro
… resistance was developed to the alkylating agent melphalan by stepwise incubation with increasing concentrations of the drug, and the degree of resistance achieved was found to be similar to that observed in the lines derived from clinically resistant patients. Cross resistance to cisplatin and …
-
Innovative cancer therapeutics based on polymers or biogenic drugs evaluated in murine tumor models
… anticancer compounds, and innovative polymeric melphalan formulations. We evaluated the in vivo characteristics of polymeric bound siRNA. We could demonstrate that the polymer FolA-PEG24-K(Stp4-C)2 is an efficient carrier for targeting siRNA to the folate receptor expressing tumor tissue of …
-
Langzeit-Nachbeobachtung von Patienten aus einer Phase III-Studie zum Vergleich zweier Hochdosischemotherapie-Protokolle bei Patienten mit multiplem Myelom im Stadium II/III („DSMM I“-Studie)
… einer Doppelhochdosis-Chemotherapie mit Melphalan und zweimaliger autologer Stammzelltransplantation und einer Einfachhochdosis-Therapie mit modifizierter Ganzkörperbestrahlung, Busulfan und Cyclophosphamid und einfacher autologer Stammzelltransplantation. Es wurde untersucht, ob sich …
-
Μελέτη της δράσης της μελατονίνης στη δομή των χρωματοσωμάτων σε λεμφοκύτταρα ανθρώπου in vitro
… effects of Melatonin and it’s combinations with melphalan and mitomycin C, which induces damage to cellular DNA. The effects of the above factors on cellular DNA were evaluated through the simultaneous study of three cytogenetic indicators: a) the levels of SCEs/cell (which reflect the DNA damage …
-
Μελέτη μοριακών μηχανισμών απόκρισης του κυττάρου στις βλάβες του DNA που επάγονται από αλκυλιωτικούς παράγοντες
… of multiple myeloma (MM) patients treated with melphalan, accumulation of DNA adducts in the p53 gene correlates with better therapeutic response, and that repair in different genes correlated with the gene transcriptional activity and the degree of local chromatin condensation Purpose: One of …
-
Etablierung einer Mikrowell-Technologie zur Testung der Suszeptibilität von Myelomzellen auf Therapeutika sowie auf die Abhängigkeit von Zell-Zell-Interaktionen
… Konzentrationen der Substanzen Bortezomib, Melphalan, Dexamethason, Daratumumab, Elotuzumab und eines SUMO-Inhibitors (SUMOi) bis zu 48h inkubiert. Außerdem wurde mittels Markierung von NK-, T- und Stromazellen des Knochenmarkes (BMMSC) deren Einfluss auf die Viabilität der MM-Zellen …
Page 1 of 4